PEOPLE - Johnson & Johnson (US) announces appointments:
This article was originally published in Clinica
Johnson & Johnson (New Brunswick, New Jersey) has announced two appointees to the office of chairman. William Weldon will replace Ralph Larson, who is set to retire in July, as chairman and CEO. Mr Weldon, who will be the sixth chairman in the company's 116-year history, joined the company in 1971 and most recently served as an executive committee member and worldwide chairman. James Lenehan, who joined the company in 1976, has been appointed as president in addition to his current role as vice-chairman. Mr Lenehan replaces Robert Wilson, who will continue to serve on the board until 2003.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.